{"title":"1008 – CLONAL HEMATOPOIESIS IN THE HUMAN BRAIN","authors":"Siddhartha Jaiswal","doi":"10.1016/j.exphem.2026.105504","DOIUrl":null,"url":null,"abstract":"<div><div>The brain has been assumed to be a site where circulating blood cells are excluded from entering under normal conditions. The resident immune cells of the brain, called microglia, originate from hematopoietic precursors in the yolk sac that self-renew for life without further contribution from adult hematopoiesis, according to current dogma. Microglia, which resemble macrophages in other tissues, are important for many neurologic processes and are implicated in brain disorders, including Alzheimer’s disease. Here, I presented our recent work challenging this paradigm. I showed that hematopoietic stem cell-derived myeloid cells can colonize the human brain in aging and differentiate into bona fide microglia. I also discussed the implications of these findings for Alzheimer’s disease.</div></div><div>The brain has been assumed to be a site where circulating blood cells are excluded from entering under normal conditions. The resident immune cells of the brain, called microglia, originate from hematopoietic precursors in the yolk sac that self-renew for life without further contribution from adult hematopoiesis, according to current dogma. Microglia, which resemble macrophages in other tissues, are important for many neurologic processes and are implicated in brain disorders, including Alzheimer’s disease. Here, I presented our recent work challenging this paradigm. I showed that hematopoietic stem cell-derived myeloid cells can colonize the human brain in aging and differentiate into bona fide microglia. I also discussed the implications of these findings for Alzheimer’s disease.</div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"162 ","pages":"Article 105504"},"PeriodicalIF":2.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301472X26001372","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The brain has been assumed to be a site where circulating blood cells are excluded from entering under normal conditions. The resident immune cells of the brain, called microglia, originate from hematopoietic precursors in the yolk sac that self-renew for life without further contribution from adult hematopoiesis, according to current dogma. Microglia, which resemble macrophages in other tissues, are important for many neurologic processes and are implicated in brain disorders, including Alzheimer’s disease. Here, I presented our recent work challenging this paradigm. I showed that hematopoietic stem cell-derived myeloid cells can colonize the human brain in aging and differentiate into bona fide microglia. I also discussed the implications of these findings for Alzheimer’s disease.
The brain has been assumed to be a site where circulating blood cells are excluded from entering under normal conditions. The resident immune cells of the brain, called microglia, originate from hematopoietic precursors in the yolk sac that self-renew for life without further contribution from adult hematopoiesis, according to current dogma. Microglia, which resemble macrophages in other tissues, are important for many neurologic processes and are implicated in brain disorders, including Alzheimer’s disease. Here, I presented our recent work challenging this paradigm. I showed that hematopoietic stem cell-derived myeloid cells can colonize the human brain in aging and differentiate into bona fide microglia. I also discussed the implications of these findings for Alzheimer’s disease.
期刊介绍:
Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.